Home LiteratureArticle Details
PMID: 8557038 Published · ppublish English Journal Article

Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1.

The EMBO journal ·Vol. 14 ·No. 24 ·1995-12-15 ·Pages 6184-92

O'Connor DJ, Lam EW, Griffin S, Zhong S, Leighton LC, Burbidge SA, Lu X

Abstract

One way in which wild-type p53 is able to regulate cell cycle progression is thought to be via the induction of its downstream target gene Waf1/CIP1, thus indirectly regulating the transcriptional activity of E2F. The E2F transcription factors are known to be key effectors of the cell cycle. We report here that there is a physical and functional interaction between p53 and two of the components of the E2F transcription factors, E2F1 and DP1. The expression of wild-type p53 can inhibit the transcriptional activity of E2F, and the expression of both E2F1 and DP1 can also downregulate p53-dependent transcription. The transcriptional activity of p53 is known to be inhibited by the direct binding of mdm2, but we demonstrate here that both E2F1 and DP1 can inhibit p53 transcriptional activity independently of mdm2. Detailed studies of protein-protein interactions have provided evidence that E2F1 and its co-operating factor DP1 can complex with p53 both in vitro and in vivo.

MeSH Terms
Animals Carrier Proteins Cell Cycle/genetics,physiology Cell Cycle Proteins Cell Line DNA-Binding Proteins/physiology E2F Transcription Factors E2F1 Transcription Factor Genes, p53 Humans In Vitro Techniques Mice Nuclear Proteins Proto-Oncogene Proteins/physiology Proto-Oncogene Proteins c-mdm2 Retinoblastoma Protein/physiology Retinoblastoma-Binding Protein 1 Transcription Factor DP1 Transcription Factors/physiology Transcription, Genetic
Chemicals
Arid4a protein, mouse Carrier Proteins Cell Cycle Proteins DNA-Binding Proteins E2F Transcription Factors E2F1 Transcription Factor E2F1 protein, human E2f1 protein, mouse Nuclear Proteins Proto-Oncogene Proteins Retinoblastoma Protein Retinoblastoma-Binding Protein 1 TFDP1 protein, human Tfdp1 protein, mouse Transcription Factor DP1 Transcription Factors MDM2 protein, human Mdm2 protein, mouse Proto-Oncogene Proteins c-mdm2
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
O'Connor D J
Ludwig Institute for Cancer Research, St Mary's Hospital Medical School, London, UK.
Lam E W
Griffin S
Zhong S
Leighton L C
Burbidge S A
Lu X
References (37)
37 references, click to expand
  1. Monoclonal antibodies specific for simian virus 40 tumor antigens.
    J Virol. 1981 Sep;39(3):861-9 PMID: 6169844
  2. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.
    Cell. 1994 Mar 25;76(6):1013-23 PMID: 8137420
  3. C-terminal truncation of the retinoblastoma gene product leads to functional inactivation.
    Proc Natl Acad Sci U S A. 1990 Jan;87(1):6-10 PMID: 1688660
  4. Suppression of human colorectal carcinoma cell growth by wild-type p53.
    Science. 1990 Aug 24;249(4971):912-5 PMID: 2144057
  5. The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.
    EMBO J. 1990 Oct;9(10):3253-60 PMID: 2145148
  6. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
    Oncogene. 1991 Oct;6(10):1791-7 PMID: 1923504
  7. Participation of p53 protein in the cellular response to DNA damage.
    Cancer Res. 1991 Dec 1;51(23 Pt 1):6304-11 PMID: 1933891
  8. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.
    Nature. 1992 Mar 19;356(6366):215-21 PMID: 1552940
  9. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli.
    J Cell Sci. 1992 Jan;101 ( Pt 1):183-9 PMID: 1569122
  10. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.
    Cell. 1992 Jun 26;69(7):1237-45 PMID: 1535557
  11. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.
    J Immunol Methods. 1992 Jul 6;151(1-2):237-44 PMID: 1378473
  12. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
    J Cell Biochem. 1992 Jun;49(2):208-15 PMID: 1400626
  13. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.
    Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9210-4 PMID: 1409626
  14. mdm2 expression is induced by wild type p53 activity.
    EMBO J. 1993 Feb;12(2):461-8 PMID: 8440237
  15. Release of the p53-induced repression on thymidine kinase promoter by single p53-binding sequence.
    Biochem Biophys Res Commun. 1993 Mar 15;191(2):662-8 PMID: 8384849
  16. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53.
    Nature. 1993 Apr 29;362(6423):857-60 PMID: 8479525
  17. Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences.
    Oncogene. 1993 Aug;8(8):2159-66 PMID: 8336941
  18. Expression of transcription factor E2F1 induces quiescent cells to enter S phase.
    Nature. 1993 Sep 23;365(6444):349-52 PMID: 8377827
  19. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation.
    Genes Dev. 1993 Oct;7(10):1850-61 PMID: 8405995
  20. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F.
    EMBO J. 1993 Nov;12(11):4317-24 PMID: 8223441
  21. Heterodimerization of the transcription factors E2F-1 and DP-1 is required for binding to the adenovirus E4 (ORF6/7) protein.
    J Virol. 1994 Aug;68(8):5027-35 PMID: 8035503
  22. DP-1: a cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 protein.
    EMBO J. 1994 Jul 1;13(13):3104-14 PMID: 8039504
  23. Interaction of p53 with MDM2 is independent of E6 and does not mediate wild type transformation suppressor function.
    Oncogene. 1994 Sep;9(9):2707-16 PMID: 8058335
  24. Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein.
    Cell. 1994 Sep 9;78(5):799-811 PMID: 8087847
  25. DP and E2F proteins: coordinating transcription with cell cycle progression.
    Curr Opin Cell Biol. 1994 Dec;6(6):859-66 PMID: 7880534
  26. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle.
    Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2403-7 PMID: 7892279
  27. In vivo association of E2F and DP family proteins.
    Mol Cell Biol. 1995 May;15(5):2536-46 PMID: 7739537
  28. E2F-5, a new E2F family member that interacts with p130 in vivo.
    Mol Cell Biol. 1995 Jun;15(6):3082-9 PMID: 7760804
  29. Cloning and characterization of human DP2, a novel dimerization partner of E2F.
    Oncogene. 1995 Jun 1;10(11):2085-93 PMID: 7784053
  30. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.
    Nature. 1995 Jun 22;375(6533):691-4 PMID: 7791903
  31. Interaction between the retinoblastoma protein and the oncoprotein MDM2.
    Nature. 1995 Jun 22;375(6533):694-8 PMID: 7791904
  32. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes?
    Cell. 1993 Nov 19;75(4):765-78 PMID: 8242748
  33. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
    Cell. 1993 Nov 19;75(4):805-16 PMID: 8242751
  34. WAF1, a potential mediator of p53 tumor suppression.
    Cell. 1993 Nov 19;75(4):817-25 PMID: 8242752
  35. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.
    Oncogene. 1993 Dec;8(12):3411-6 PMID: 8247544
  36. p21 is a universal inhibitor of cyclin kinases.
    Nature. 1993 Dec 16;366(6456):701-4 PMID: 8259214
  37. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.
    Mol Cell Biol. 1981 Feb;1(2):101-10 PMID: 6100960
Article Info
Journal
The EMBO journal
Abbr.
EMBO J
ISSN
0261-4189
Published
1995-12-15
Pages
6184-92
Language
English
Region
England
NLM ID
8208664
PMCID
PMC394743
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]